发明名称 COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE
摘要 <p>Compounds of formula (I), salts and solvates thereof are provided: wherein Ar is selected from phenyl, pyridyl, furanyl and thienyl, each optionally substituted with one or more groups Y; and each Y group is independently selected from the group consisting of: halo, C&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, haloC&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, C&lt;SUB&gt;1-4&lt;/SUB&gt;alkoxy, cyano, C(O) C&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, NHSO&lt;SUB&gt;2&lt;/SUB&gt;C&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, NMeSO2C&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, NHCOC&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, NMeCOC&lt;SUB&gt;1-4&lt;/SUB&gt;aIkyl, SOC&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, SO&lt;SUB&gt;2&lt;/SUB&gt;C&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, and CO&lt;SUB&gt;2&lt;/SUB&gt;C&lt;SUB&gt;1-4&lt;/SUB&gt;alkyl, or two Y groups together form a cyclic group -0(CH&lt;SUB&gt;2&lt;/SUB&gt;)O-. Processes for preparation, and uses thereof in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.</p>
申请公布号 WO2007090841(A1) 申请公布日期 2007.08.16
申请号 WO2007EP51136 申请日期 2007.02.06
申请人 GLAXO GROUP LIMITED;ANDREOTTI, DANIELE;WARD, SIMON, EDWARD 发明人 ANDREOTTI, DANIELE;WARD, SIMON, EDWARD
分类号 C07D307/22;A61K31/34;A61P25/00;C07D401/10;C07D409/10 主分类号 C07D307/22
代理机构 代理人
主权项
地址